Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersRachael Z Stolzenberg-Solomon, Eric J Jacobs, Alan A Arslan, et al.
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer CancersChristian C Abnet, Yu Chen, Wong-Ho Chow, et al.
Cancer Research|August 30, 2019
High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort ConsortiumLauren C Peres, Adrianne R Mallen, Mary K Townsend, et al.
Cancer Research|April 7, 2017
Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort ConsortiumJennifer Ose, Elizabeth M Poole, Helena Schock, et al.
British Journal of Cancer|September 6, 2017
Anti-Mullerian hormone and endometrial cancer: a multi-cohort studyRenée T Fortner, Helena Schock, Seungyoun Jung, et al.
American Journal of Epidemiology|June 22, 2010
Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer CancersMark P Purdue, D Michal Freedman, Susan M Gapstur, et al.
Fertility and Sterility|April 4, 2017
Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal womenSeungyoun Jung, Naomi Allen, Alan A Arslan, et al.
International Journal of Cancer|September 19, 2017
Anti-Müllerian hormone and risk of ovarian cancer in nine cohortsSeungyoun Jung, Naomi Allen, Alan A Arslan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studiesAnita Koushik, David J Hunter, Donna Spiegelman, et al.
JAMA|May 18, 2026
Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk ModelHana Zahed, Xiaoshuang Feng, Karine Alcala, et al.
Pageof 15